Core Viewpoint - Ningbo Rongbai New Energy Technology Co., Ltd. has received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to alleged misleading statements related to significant contract announcements, leading to potential legal consequences for the company and its investors [1][4]. Group 1: Investigation Details - The CSRC has initiated an investigation based on the notice issued on January 18, 2026, citing violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][4]. - The investigation is focused on the company's failure to disclose information accurately and timely, which may have caused financial losses to investors [4]. Group 2: Investor Compensation - A preliminary compensation range has been established for investors who purchased Rongbai Technology (688005) stock between its listing and January 18, 2026, and sold or held the stock after January 19, 2026 [2][4]. - Investors seeking compensation must provide original transaction statements stamped by their brokerage, showing all trading records from the initial purchase date to the current date, including remaining shares for those still holding the stock [2][4][5]. - Additional required documents for compensation include copies of the investor's ID and a securities account inquiry issued by the brokerage [5].

Core Viewpoint - Zhejiang Sunflower Health Technology Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following concerns about misleading statements in its restructuring proposal [1][5]. Group 1: Investigation and Legal Proceedings - On January 15, 2026, Zhejiang Sunflower announced it received a notice from the CSRC regarding the initiation of an investigation due to alleged violations of the Securities Law and Administrative Penalty Law [1][5]. - The CSRC's investigation was prompted by market doubts regarding the actual production capacity and business model of the restructuring target disclosed on September 22, 2025 [1][5]. - The Zhejiang Securities Regulatory Bureau has found that the restructuring proposal may contain misleading statements, leading to the ongoing investigation [1][5]. Group 2: Investor Compensation and Legal Actions - Investors who suffered losses due to the alleged violations can register for compensation claims through legal representation offered by Shanghai Hanlian Law Firm [2][6]. - The conditions for compensation claims include purchasing Sunflower stocks or bonds between September 22, 2025, and January 14, 2026, and selling or holding them after January 15, 2026 [2][6]. - Legal experts emphasize that while investors can file lawsuits without an administrative penalty decision, such a decision is still considered a necessary prerequisite for successful claims [3][7]. Group 3: Documentation for Claims - Investors seeking to register for compensation must provide specific documentation, including a copy of their ID, a securities account confirmation, and transaction records from the initial purchase to the present [8].

Core Viewpoint - Tianpu Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for alleged significant omissions in announcements regarding abnormal stock trading fluctuations, which has raised market concerns [1][3]. Group 1: Regulatory Actions - On January 9, 2026, Tianpu Co., Ltd. received a notice from the CSRC regarding the initiation of an investigation due to suspected major omissions in its announcements related to abnormal stock trading [1][2]. - The Shanghai Stock Exchange has also initiated regulatory procedures regarding the related matters, indicating a comprehensive approach to address the situation [3]. Group 2: Stock Performance and Market Reaction - Tianpu Co., Ltd. has experienced a remarkable stock price increase of over 16 times in 2025, currently trading at 218.02 yuan per share, with a market capitalization of 29.23 billion yuan [2][3]. - The company has issued a risk warning, stating that it does not have any artificial intelligence-related technology or personnel, nor does it plan to engage in artificial intelligence-related business [2][3]. Group 3: Investor Implications - Investors who purchased Tianpu shares before January 9, 2026, and sold or held them after January 10, 2026, may be eligible for compensation due to the ongoing investigation [4].

Core Viewpoint - *ST Panda has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged violations of information disclosure laws, which may lead to compensation claims from affected investors [1][2][3]. Group 1: Investigation Details - On December 29, 2025, *ST Panda announced that it received a formal notice from the CSRC indicating that the company is under investigation for suspected violations of information disclosure regulations [1][2]. - The notice is numbered 0132025017 and cites violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][2]. Group 2: Investor Compensation - Investors who purchased *ST Panda shares between December 2, 2024, and April 28, 2025, and held them until the market close on April 28, 2025, may be eligible for compensation [3][4]. - The compensation process will be contingent upon the findings of the CSRC investigation and will ultimately be determined by a court ruling [3][4]. Group 3: Required Documentation for Claims - Affected investors must prepare specific documentation to support their compensation claims, including: 1. Original transaction statements for *ST Panda shares, stamped by the brokerage [3]. 2. Copies of the investor's identification [4]. 3. A confirmation letter from the brokerage regarding the investor's account [4].

Core Viewpoint - Taiyuan Heavy Industry Co., Ltd. has been penalized by the China Securities Regulatory Commission (CSRC) for falsifying financial records related to a wind power project, leading to significant discrepancies in reported revenues and profits from 2014 to 2021 [1][5][9]. Financial Misstatements - In 2014, the company overstated revenue by approximately 756.67 million yuan, which was 8.39% of the reported revenue, and overstated profit by about 155.35 million yuan, constituting 763.89% of the reported profit [1][9]. - In 2015, the company understated revenue by about 43.87 million yuan, which was 0.64% of the reported revenue, while overstating profit by approximately 13.03 million yuan, representing 34.83% of the reported profit [2][10]. - In 2016, the company overstated revenue by around 751.89 million yuan, accounting for 17.58% of the reported revenue, and overstated costs by approximately 786.07 million yuan, which was 18.68% of the reported costs [2][10]. - In 2017, the company understated revenue by about 185.21 million yuan, which was 2.58% of the reported revenue, while overstating profit by approximately 16.53 million yuan, representing 27.37% of the reported profit [3][11]. - In 2018, the company understated revenue by approximately 92.61 million yuan, which was 1.44% of the reported revenue, and overstated profit by about 120.75 million yuan, constituting 189.76% of the reported profit [3][11]. - In 2020, the company understated revenue by around 165.72 million yuan, which was 1.92% of the reported revenue, and understated profit by approximately 11.74 million yuan, representing 15.52% of the reported profit [3][11]. - In 2021, the company understated revenue by about 93.41 million yuan, which was 1.12% of the reported revenue, and understated profit by approximately 45.61 million yuan, constituting 25.3% of the reported profit [3][11]. Regulatory Actions - The CSRC's Shanxi Regulatory Bureau has ordered Taiyuan Heavy Industry to correct its financial statements and has issued warnings along with fines to the company and responsible personnel [5][13]. - The company had previously received a notice of investigation from the CSRC on July 26, 2025, and a prior notice of administrative penalty on November 1, 2025 [5][13]. Legal Implications for Investors - Investors who suffered losses due to the company's misstatements can seek compensation through legal channels, as outlined by the relevant laws and regulations [6][14]. - The conditions for filing claims include having purchased the company's securities between April 11, 2015, and July 25, 2025, and having sold or continued to hold them after July 26, 2025 [6][14].

Core Viewpoint - Hainan Huluwa Pharmaceutical Group Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to potential civil compensation claims from affected investors [1][2][6]. Group 1: Company Announcement - On March 15, 2025, Huluwa announced that it received a notice of investigation from the CSRC due to alleged information disclosure violations by the company and its chairman, Liu Jingping [1][6]. - The CSRC previously issued an administrative regulatory decision on the same day, identifying inaccuracies in the financial disclosures of the 2023 annual report, including revenue and profit figures [6]. Group 2: Financial Data Correction - On April 29, 2025, Huluwa released a correction notice regarding prior accounting errors affecting the financial data in the 2023 annual report and the 2024 semi-annual, first quarter, and third quarter reports [1][6]. Group 3: Investor Compensation - Investors who purchased Huluwa's stocks or bonds between April 27, 2024, and March 14, 2025, and sold or continued to hold them after March 15, 2025, may register for compensation claims [2][6]. - The compensation scope includes investment differences, commissions, stamp duties, and interest losses due to the alleged fraudulent activities [2][6]. Group 4: Legal Proceedings - Investors are advised that while they can initiate lawsuits without an administrative penalty decision, the lack of such a decision may increase the risk of losing the case [3][7]. - The progress of civil compensation lawsuits may be affected by the company's potential delisting or bankruptcy proceedings [8].

Core Viewpoint - Zhuoran Co., Ltd. has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged violations of information disclosure laws, which may lead to compensation claims from affected investors [1][5]. Group 1: Investigation Details - Zhuoran Co., Ltd. is under investigation by the CSRC for suspected violations of information disclosure laws as per the Securities Law of the People's Republic of China and the Administrative Penalty Law [1][5]. - The investigation was officially communicated through a notice issued on December 20, 2025 [1][5]. Group 2: Compensation Claims - Investors who purchased Zhuoran shares (688121) between September 6, 2021, and December 20, 2025, and sold or continued to hold the shares after December 20, 2025, may be eligible for compensation [2][5]. - The preliminary compensation criteria are subject to final court rulings [2][5]. Group 3: Required Documentation for Claims - Investors must provide original transaction statements for Zhuoran shares, stamped by their brokerage, showing all trading records from the first purchase to the current date [2][5]. - Additional required documents include copies of the investor's ID, a securities account inquiry from the brokerage, and contact information [3][6].

Core Viewpoint - The lawsuit against Xilong Science Co., Ltd. has progressed, with investors winning the final judgment and receiving compensation, while the company shows willingness to mediate [1][2]. Group 1: Legal Developments - Investors represented by Zhao Jingguo's legal team have achieved a final victory in their lawsuit against Xilong Science, with compensation awarded [1][2]. - The company received a notice of investigation from the China Securities Regulatory Commission (CSRC) on May 6, 2023, due to suspected violations of information disclosure laws [1][4]. - On July 7, 2023, Xilong Science was issued an administrative penalty decision by the CSRC, confirming that the company inflated revenue by fabricating trade activities involving ethylene glycol and methanol [1][4]. Group 2: Investor Compensation Conditions - Investors who purchased and held shares of Xilong Science between April 29, 2021, and April 28, 2023, are eligible to register for compensation, regardless of whether they sold their shares after April 29, 2023 [3][5]. - The specific compensation range will be determined by the court [5].

Core Viewpoint - The investor lawsuit against Dalian Zhiyun Automation Equipment Co., Ltd. (ST Zhiyun) is progressing, with indications of a willingness to mediate from the company [1][2]. Group 1: Legal Developments - The case involves a series of lawsuits where a first-instance victory has already been achieved for some investors [1]. - The China Securities Regulatory Commission (CSRC) issued a notice of investigation to the company on April 18, 2024, due to suspected violations of information disclosure laws [1]. - On March 14, 2025, the company and related parties received an administrative penalty decision from the Dalian Securities Regulatory Bureau [1]. Group 2: Financial Misconduct - Zhiyun's acquisition of 81.32% of Jiutian Zhongchuang in 2020 led to the latter being included in Zhiyun's consolidated financial statements [1]. - In 2022, Jiutian Zhongchuang falsely recognized sales revenue of 59.7345 million yuan and profit of 24.1123 million yuan from Jiangxi Mizhan Technology Co., which accounted for 13.27% and 7.09% of Zhiyun's total disclosed revenue and profit, respectively [1]. Group 3: Investor Compensation - Investors who purchased shares between April 28, 2023, and April 14, 2024, and still hold them, may voluntarily register for compensation through the "Sina Stockholder Rights Protection Platform" [2][3]. - The specific compensation range will be determined by the court [3].

Core Viewpoint - Helitai Technology Co., Ltd. (stock code: 002217) has received a notice from the China Securities Regulatory Commission (CSRC) regarding a formal investigation for suspected violations of information disclosure laws [1][4]. Group 1: Investigation Details - The CSRC issued a formal notice (case number: 0262025003) on April 28, 2025, indicating that the company is under investigation for alleged violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][4]. - Helitai stated that during the investigation, it will actively cooperate with the CSRC and comply with regulatory disclosure requirements [4]. Group 2: Investor Compensation - Investors who purchased Helitai shares before or on April 28, 2025, and still held them at the close of trading on that date may be eligible for compensation [2][5]. - Required materials for compensation claims include original transaction statements stamped by the brokerage, copies of the investor's ID, and a confirmation of the securities account from the brokerage [5][6].